Pantelis Sarafidis

19.1k total citations · 2 hit papers
361 papers, 9.2k citations indexed

About

Pantelis Sarafidis is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pantelis Sarafidis has authored 361 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 199 papers in Cardiology and Cardiovascular Medicine, 126 papers in Nephrology and 80 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pantelis Sarafidis's work include Blood Pressure and Hypertension Studies (145 papers), Dialysis and Renal Disease Management (80 papers) and Cardiovascular Health and Disease Prevention (48 papers). Pantelis Sarafidis is often cited by papers focused on Blood Pressure and Hypertension Studies (145 papers), Dialysis and Renal Disease Management (80 papers) and Cardiovascular Health and Disease Prevention (48 papers). Pantelis Sarafidis collaborates with scholars based in Greece, United States and United Kingdom. Pantelis Sarafidis's co-authors include George L. Bakris, Anastasios N. Lasaridis, Panagiotis I. Georgianos, Luís M. Ruilope, Charalampos Loutradis, Carmine Zoccali, Αikaterini Papagianni, Nitin Khosla, Athanasios Saratzis and Peter M. Nilsson and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Pantelis Sarafidis

343 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The systemic nature of CKD

2017 300 citations Carmine Zoccali, Alberto Ortíz et al. Nature Reviews Nephrology profile →
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association

2023 129 citations Carmine Zoccali, Francesca Mallamaci et al. Cardiovascular Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pantelis Sarafidis Greece	48	4.2k	2.9k	2.6k	1.7k	1.5k	361	9.2k
Rajiv Agarwal United States	51	4.0k 1.0×	3.4k 1.2×	2.7k 1.1×	1.9k 1.1×	1.8k 1.2×	284	9.9k
Rajiv Agarwal United States	61	4.8k 1.2×	4.5k 1.5×	2.7k 1.1×	2.1k 1.2×	1.8k 1.2×	233	11.1k
Sunil Bhandari United Kingdom	39	4.4k 1.0×	3.7k 1.3×	1.7k 0.7×	1.6k 1.0×	1.9k 1.3×	203	11.3k
Bo Feldt‐Rasmussen Denmark	47	3.5k 0.9×	4.2k 1.4×	3.3k 1.3×	1.4k 0.8×	1.1k 0.8×	249	9.9k
Adam Whaley‐Connell United States	53	3.4k 0.8×	2.5k 0.9×	3.6k 1.4×	1.7k 1.0×	785 0.5×	217	10.4k
Sandra J. Taler United States	41	5.8k 1.4×	1.3k 0.4×	1.9k 0.8×	2.1k 1.3×	1.7k 1.2×	100	11.5k
Yoshinari Yasuda Japan	40	2.3k 0.6×	4.1k 1.4×	1.5k 0.6×	1.6k 1.0×	1.6k 1.1×	152	10.6k
Johan Ärnlöv Sweden	56	4.2k 1.0×	2.7k 0.9×	2.0k 0.8×	1.5k 0.9×	1.2k 0.8×	299	12.6k
Aimun Ahmed United Kingdom	8	3.5k 0.8×	2.4k 0.8×	1.3k 0.5×	1.2k 0.7×	1.1k 0.7×	19	7.0k
Shahnaz Shahinfar United States	31	6.1k 1.5×	5.2k 1.8×	4.3k 1.7×	900 0.5×	1.2k 0.8×	54	11.0k

Countries citing papers authored by Pantelis Sarafidis

Since Specialization

Citations

This map shows the geographic impact of Pantelis Sarafidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pantelis Sarafidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pantelis Sarafidis more than expected).

Fields of papers citing papers by Pantelis Sarafidis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pantelis Sarafidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pantelis Sarafidis. The network helps show where Pantelis Sarafidis may publish in the future.

Co-authorship network of co-authors of Pantelis Sarafidis

This figure shows the co-authorship network connecting the top 25 collaborators of Pantelis Sarafidis. A scholar is included among the top collaborators of Pantelis Sarafidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pantelis Sarafidis. Pantelis Sarafidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Theodorakopoulou, Marieta, et al.. (2025). A salty symphony: unraveling the tale of uromodulin and sodium sensitivity. Journal of Human Hypertension. 39(5). 320–333.

Fernández‐Fernández, Beatriz, et al.. (2025). Very low SBP targets and the boom-and-bust cycle of benefit and adverse kidney events. Nephrology Dialysis Transplantation. 40(9). 1646–1649. 1 indexed citations

García-Carro, Clara & Pantelis Sarafidis. (2025). Does low-dose spironolactone increase cardiovascular protection in patients with chronic kidney disease?. Clinical Kidney Journal. 18(3). sfaf038–sfaf038. 1 indexed citations

Sarafidis, Pantelis. (2024). Use of ACEi/ARBs, SGLT2 inhibitors and MRAs can help us reach the therapeutic ceiling in CKD. Clinical Kidney Journal. 17(2). 5 indexed citations

Theodorakopoulou, Marieta, Christopher Mayer, Vasileios Kamperidis, et al.. (2024). The association of sex differences in ambulatory blood pressure with cardiovascular events and mortality in dialysis patients. Journal of Human Hypertension. 38(12). 789–795. 2 indexed citations

Theodorakopoulou, Marieta, et al.. (2024). Dialysate Sodium Levels, Ambulatory Aortic Blood Pressure, and Arterial Stiffness in Hemodialysis Patients. American Journal of Hypertension. 38(1). 18–26. 1 indexed citations

Zoccali, Carmine, Francesca Mallamaci, Jean‐Michel Halimi, et al.. (2024). Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework. Nature Reviews Nephrology. 20(4). 266–266. 1 indexed citations

Ekart, Robert, et al.. (2024). Dialysate sodium and short-term blood pressure variability in patients with intradialytic hypertension: a randomized crossover study. Journal of Human Hypertension. 38(11). 750–757. 2 indexed citations

Ekart, Robert, Αντώνιος Καρπέτας, Marieta Theodorakopoulou, et al.. (2024). #1478 Effect of low vs standard dialysate sodium on 48-h ambulatory blood pressure in patients with intradialytic hypertension: a randomized crossover study. Nephrology Dialysis Transplantation. 39(Supplement_1). 1 indexed citations

10.

Stafylas, Panagiotis, et al.. (2023). #5632 THE CLINICAL AND ECONOMIC BURDEN OF CHRONIC KIDNEY DISEASE IN GREECE. Nephrology Dialysis Transplantation. 38(Supplement_1). 3 indexed citations

11.

Sarafidis, Pantelis, Charles J. Ferro, Maria Eleni Alexandrou, et al.. (2023). Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA). Clinical Kidney Journal. 16(11). 1885–1907. 20 indexed citations

12.

Gavriilaki, Eleni, Αntonios Lazaridis, Panagiota Anyfanti, et al.. (2023). Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure. Journal of Human Hypertension. 37(12). 1105–1111. 1 indexed citations

13.

Januszewicz, Andrzej, Paolo Mulatero, Piotr Dobrowolski, et al.. (2022). Cardiac Phenotypes in Secondary Hypertension. Journal of the American College of Cardiology. 80(15). 1480–1497. 9 indexed citations

14.

Halimi, Jean‐Michel, Alberto Ortíz, Pantelis Sarafidis, et al.. (2021). Hypertension in kidney transplantation: a consensus statement of the ‘hypertension and the kidney’ working group of the European Society of Hypertension. Journal of Hypertension. 39(8). 1513–1521. 19 indexed citations

15.

Sarafidis, Pantelis, Sven Martens, Athanasios Saratzis, et al.. (2021). Diseases of the Aorta and Kidney Disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Cardiovascular Research. 118(12). 2582–2595. 12 indexed citations

16.

Pisano, Anna, Francesca Mallamaci, Graziella D’Arrigo, et al.. (2021). Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis. Clinical Kidney Journal. 15(1). 31–42. 18 indexed citations

17.

Schoina, Maria, Charalampos Loutradis, Ioanna Minopoulou, et al.. (2020). Ambulatory Blood Pressure Trajectories and Blood Pressure Variability in Diabetic and Non-Diabetic Chronic Kidney Disease. American Journal of Nephrology. 51(5). 411–420. 4 indexed citations

18.

Karras, Spyridon Ν., et al.. (2018). The optimal blood pressure target in diabetes mellitus: a quest coming to an end?. Journal of Human Hypertension. 32(10). 641–650. 11 indexed citations

19.

Sarafidis, Pantelis, Charalampos Loutradis, Αντώνιος Καρπέτας, et al.. (2017). Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients. Hypertension. 70(1). 148–157. 86 indexed citations

20.

Stafylas, Panagiotis, Pantelis Sarafidis, Anastasios N. Lasaridis, et al.. (2007). Cost-effectiveness of losartan in diabetic nephropathy: a Greek perspective. Journal of Nephrology. 20(6). 703–715. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact